当前位置:首页 - 行情中心 - 丹娜生物(920009) - 财务分析 - 现金流量表

丹娜生物

(920009)

  

流通市值:3.08亿  总市值:23.71亿
流通股本:1008.00万   总股本:7754.60万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金202,236,362.37129,541,976.9357,009,121.08281,280,921.26
  收到的税费返还1,051,340.41--5,844,423.83
  收到其他与经营活动有关的现金4,326,371.26721,579.81222,249.5914,917,451.43
  经营活动现金流入小计207,614,074.04130,263,556.7457,231,370.67302,042,796.52
  购买商品、接受劳务支付的现金45,290,878.8724,868,874.199,910,777.3549,275,207.24
  支付给职工以及为职工支付的现金66,013,941.0446,070,538.8227,843,457.6778,227,087.21
  支付的各项税费29,154,907.4721,292,505.711,417,795.8739,126,577.89
  支付其他与经营活动有关的现金15,813,646.9212,755,190.569,240,111.3628,831,078.36
  经营活动现金流出小计156,273,374.3104,987,109.2758,412,142.25195,459,950.7
  经营活动产生的现金流量净额51,340,699.7425,276,447.47-1,180,771.58106,582,845.82
二、投资活动产生的现金流量:
  收回投资收到的现金1,343,000,0001,049,500,000442,000,0003,034,050,000
  取得投资收益收到的现金8,271,298.256,413,453.52840,860.724,599,998.24
  处置固定资产、无形资产和其他长期资产收回的现金净额318,510255,080150,00045,680
  投资活动现金流入小计1,351,589,808.251,056,168,533.52442,990,860.723,038,695,678.24
  购建固定资产、无形资产和其他长期资产支付的现金32,913,925.1718,199,081.67790,188.455,816,741.64
  投资支付的现金1,623,000,0001,167,000,000601,500,0003,186,050,000
  投资活动现金流出小计1,655,913,925.171,185,199,081.67602,290,188.453,191,866,741.64
  投资活动产生的现金流量净额-304,324,116.92-129,030,548.15-159,299,327.73-153,171,063.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金---136,800,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---136,800,000
  偿还债务支付的现金---0
  分配股利、利润或偿付利息支付的现金54,836,10027,695,00000
  支付其他与筹资活动有关的现金1,147,678.34746,578.52020,893,926.25
  筹资活动现金流出小计55,983,778.3428,441,578.52020,893,926.25
  筹资活动产生的现金流量净额-55,983,778.34-28,441,578.520115,906,073.75
四、汇率变动对现金及现金等价物的影响-171,079.76-121,633.15-35,995.75-157,655.03
五、现金及现金等价物净增加额-309,138,275.28-132,317,312.35-160,516,095.0669,160,201.14
  加:期初现金及现金等价物余额344,188,296.87344,188,296.87344,188,296.87275,028,095.73
  期末现金及现金等价物余额35,050,021.59211,870,984.52183,672,201.81344,188,296.87
补充资料:
  净利润-45,906,554.77-97,742,993.21
  资产减值准备-208,754.65-690,801.92
  固定资产和投资性房地产折旧-2,888,739.68-6,518,829.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,888,739.68-6,518,829.35
  无形资产摊销-171,389.4-283,972.74
  长期待摊费用摊销-1,019,349.23-2,817,826.56
  处置固定资产、无形资产和其他长期资产的损失--119,863.13--
  固定资产报废损失-30,348.48-11,512.64
  公允价值变动损失--712,527.86--26,551.67
  财务费用-170,079.69-264,079.31
  投资损失--4,739,621.98--8,524,567.69
  递延所得税-1,199,559.24--1,328,748.62
  其中:递延所得税资产减少-1,227,280.23--529,476.99
    递延所得税负债增加--27,720.99--799,271.63
  存货的减少--3,186,258.36--6,444,509.35
  经营性应收项目的减少--1,375,392.26--7,663,705.63
  经营性应付项目的增加--16,771,828.37-18,969,644.91
  其他--100,494.28-1,737,815.31
  现金的期末余额-211,870,984.52-344,188,296.87
  减:现金的期初余额-344,188,296.87-275,028,095.73
  现金及现金等价物的净增加额--132,317,312.35-69,160,201.14
公告日期2026-10-232026-08-242026-04-292026-04-08
审计意见(境内)标准无保留意见
TOP↑